vialroom

#cagrilintide 2026-04-15

Wednesday39 messages9 participantstimes are UTC
Highlights from this day
  • area_percent — amylin is co-secreted with insulin from beta cells. it slows gastric emptying and signals satiety centrally 11:30
  • taper_tess — the same door analogy is what finally made this click for me two years ago 11:33
  • area_percent — which fits the mechanism reasonably well. amylin acting on gastric emptying and hindbrain satiety pathways 11:41
  • ivy_injects — minutes to a week is a hell of a bit of engineering 14:16
  • taper_tess — standing rule and it keeps needing saying 15:34
SS

changed my mind on this, i started thinking amylin was the interesting bit and now i think its the pairing, thats just me

SD

the nausea felt different rather than less, more fullness and less of the queasy wave

RS

genuine question i titrated over twice as many weeks as i did on semaglutide and that was right for me

🧪10🙏4⚠️9
SS

noticed something around week 32 on monotherapy, well after i had given up expecting to, your mileage will differ

👀3❤️2
RS

dosing them on different days made no difference i could detect, still working it out

cagrisema thats it

AP

no. amylin analogue. completely different peptide family and a different set of receptors

amylin is co-secreted with insulin from beta cells. it slows gastric emptying and signals satiety centrally

AP

same outcome, different door. thats exactly why combining them is interesting

TT

the same door analogy is what finally made this click for me two years ago

🧠9

sema nausea was a wave. cagri was more like being uncomfortably full all the time

DV

the full feeling is easier to work around and harder to ignore. i genuinely dont know which is worse

TT

mine matched that. less queasy, more early satiety. i put my fork down mid meal without deciding to

AP

which fits the mechanism reasonably well. amylin acting on gastric emptying and hindbrain satiety pathways

Cited study
Cagrilintide dose-finding phase 2 in overweight and obesity
Lancet · 2021
once-weekly amylin analogue, dose ranging up to 4.5 mg, with an active comparator arm

monotherapy weight loss in that trial was real but modest next to what sema was doing at the time

CH

and thats the argument that runs all week in here, so grab a seat

DV

worth knowing the half-life is long, roughly weekly, so its a once a week injection like the others

AP

yes, engineered for weekly. native amylin has a half-life of minutes

AP

acylation and sequence changes. same general trick as the GLP-1 analogues, different starting peptide

TT

the older one people bring up is pramlintide, which was three injections a day with meals

TT

slower in my experience. see the conversation below, thats the whole other argument

DV

yes and it was a lot in month one. it settled. i would not want to relive weeks two to four though

CH

and if it does not settle, that is a doctor conversation rather than a hold the dose conversation